Form 4: CONMED CIO Glaze Exercises RSUs, Sells Shares for Tax

CONMED's Chief Information Officer, Richard Glaze, settled vested restricted stock units and subsequently sold a portion of the resulting common stock to cover tax obligations.

Summary

• Richard Glaze, CONMED's Chief Information Officer, engaged in transactions involving company stock on November 20, 2025.
• Glaze acquired 375 shares of CONMED Common Stock through the settlement of vested Restricted Stock Units (RSUs) at a price of $0 per share.
• Concurrently, 118 shares of Common Stock were disposed of at a price of $40.63 per share to satisfy tax withholding requirements related to the RSU settlement.
• Following these transactions, Glaze directly beneficially owns 257 shares of Common Stock and 750 Restricted Stock Units.
• The derivative securities (RSUs) have an expiration date of November 20, 2033.

Sentiment

Score: 5

Explanation: The filing reports a standard insider transaction involving the vesting and settlement of restricted stock units and a subsequent sale of shares to cover tax liabilities, which is a routine event for executive equity compensation and generally considered neutral.

Positives

• The acquisition of 375 shares through RSU settlement indicates vesting and continued equity ownership by a key executive, aligning interests with shareholders.

Negatives

• The sale of 118 shares, while for tax purposes, reduces the executive's direct common stock holdings.

Future Outlook

NA

Industry Context

This filing details a routine insider transaction involving the settlement of restricted stock units and subsequent tax-related share sale, which is a common occurrence for executives receiving equity compensation. It does not provide broader industry context or specific trends.

Stakeholder Impact

• Shareholders: The transaction represents a routine executive compensation event with minimal direct impact on the company's overall share structure or valuation. It signifies continued executive equity interest.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

This Form 4 details a standard executive compensation event involving the vesting and settlement of Restricted Stock Units (RSUs) and a subsequent sale of shares to cover tax obligations. Such routine transactions typically do not provide new material information that would warrant a change in investment recommendation. The executive continues to hold a significant number of RSUs, indicating ongoing alignment with shareholder interests, thus a 'hold' recommendation is appropriate.

Keywords

CONMED, CNMD, Form 4, insider transaction, RSU, restricted stock units, executive compensation, beneficial ownership, Richard Glaze